Bad management makes bad funding decisions and the shareholder gets screwed (again) + When is the management team clown show going to get some real money. Funding that doesn't continually screw the shareholders who have supported this deal. And all the cheerleader fanbois who are going to tell me that "this is how its done in microcap deals - WW is a genius" - No it isnt./ and no, hes not.
Good solid deals with strong organized management teams that impress with knowledge, experience, passion, vision, leadership and discipline get real funding. Deals that have assets and that are cashflowing get money thrown at them. SO which of these three categories is SGBY lacking in?
Something like 900 MILLION dollars in equity investment has flowed into publicly traded cannabis deals in the last 9 months in North America and all that this management team can continue to deliver on a regular basis is funding from the lowest of the low high interest, screw the shareholder with dilution and share dumping lenders.
Where are the single high net worth Angel investors writing checks for $100,000 - $500,000 where are the institutional investors with $2,000,000 - $20,000,000 - people who believe in and have confidence in the management team to deliver in a marketplace that we all agree is a sector no brainer with national and international expansion fast on the horizon. Why cant this management group secure real funding from real investors.
The market is there. Cannabis testing is a simple awesome business model. They have the assets in place. They have cash flow. They have all of these things that INVESTORS love about small cap deals - So why is that this management team cant secure any funding solutions that dont involve screwing the shareholder.
They have never bought down a note. The management team has let every note mature and get fully converted (screwing the shareholders) The management team attempts to deflect some of the damage with limp, lame press releases about non events or announcing a letter of intent - but it never helps. As we see today.
When we get some traction and some share price movement and stability to the positive reflecting the potential of the deal - SLAM another note goes out and the share price gets hammered and the share count total balloons another little more (again)
I for one am sick of this garbage. This CEO needs to take control of this situation and explain why he consistently cannot raise real money and can only get funding from lowest of the low. From people who have no interest at all in the future of the company - only in their 15 points in 180 days or to just dump a massive amount of stock in a short time period, to average down the share price which likely inflates the number of shares held by other note holders or even their own notes that have a future maturity date. (dont think there is no collusion or scheming to drive down prices between the various entities issuing these class of notes.
Where is the 3 million dollars that was supposed to be available in a previous press release last month. Where is the follow up on the fact that the lab they issued an LOI on to purchase in Boston is in fact owned outright by a HUGE operating lab in Colorado. Why did the Florida lab deal get leaked before the announcement. We are 5 months from 2018 and 18 evio labs. We are 10 months since that statement was issued and - no new labs -
What is going on? This management team is not doing their jobs. They apparently cant raise funding from legit investors.
They definitely do not know how to communicate with shareholders or the investment community. The vibe i get is that management is treating this as though its their own toy, completely ignoring what is in fact, their first responsibility, to that of the shareholder.
AI
